Apyx Medical Stock Performance
| APYX Stock | USD 1.69 0.24 16.55% |
On a scale of 0 to 100, Apyx Medical holds a performance score of 7. The firm shows a Beta (market volatility) of 0.75, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Apyx Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Apyx Medical is expected to be smaller as well. Please check Apyx Medical's semi variance, as well as the relationship between the rate of daily change and relative strength index , to make a quick decision on whether Apyx Medical's price patterns will revert.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Apyx Medical are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Apyx Medical showed solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Wall Street SWOT Apyx Medical stock faces headwinds amid unique tech potential - Investing.com | 09/27/2024 |
2 | Disposition of 7173 shares by Swandal Craig A. of Apyx Medical at 9.42 subject to Rule 16b-3 | 09/30/2024 |
3 | Disposition of tradable shares by Vizirgianakis Stavros G. of Apyx Medical subject to Rule 16b-3 | 10/01/2024 |
4 | Apyx Upgraded to Buy Heres What You Should Know | 10/03/2024 |
5 | Acquisition by Todd Hornsby of 15000 shares of Apyx Medical at 1.77 subject to Rule 16b-3 | 10/10/2024 |
6 | Chuck Royces Strategic Acquisition of Apyx Medical Corp Shares | 10/15/2024 |
7 | Bullish Apyx Medical Insiders Loaded Up On US2.27m Of Stock | 10/31/2024 |
8 | Perkins Capital Management Inc. Has 270,000 Stake in Apyx Medical Co. | 11/07/2024 |
9 | Apyx Medical Corporation Announces 7,000,000 Million Registered Direct Offering | 11/08/2024 |
10 | Apyx Medical Corporation to Participate in the Piper Sandler 36th Annual Healthcare Conference | 11/27/2024 |
| Begin Period Cash Flow | 10.2 M |
Apyx |
Apyx Medical Relative Risk vs. Return Landscape
If you would invest 135.00 in Apyx Medical on August 31, 2024 and sell it today you would earn a total of 34.00 from holding Apyx Medical or generate 25.19% return on investment over 90 days. Apyx Medical is currently generating 0.504% in daily expected returns and assumes 5.6658% risk (volatility on return distribution) over the 90 days horizon. In different words, 50% of stocks are less volatile than Apyx, and 90% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Apyx Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Apyx Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Apyx Medical, and traders can use it to determine the average amount a Apyx Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.089
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | APYX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.67 actual daily | 50 50% of assets are less volatile |
Expected Return
| 0.5 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Apyx Medical is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Apyx Medical by adding it to a well-diversified portfolio.
Apyx Medical Fundamentals Growth
Apyx Stock prices reflect investors' perceptions of the future prospects and financial health of Apyx Medical, and Apyx Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Apyx Stock performance.
| Return On Equity | -1.1 | ||||
| Return On Asset | -0.22 | ||||
| Profit Margin | (0.58) % | ||||
| Operating Margin | (0.46) % | ||||
| Current Valuation | 74.45 M | ||||
| Shares Outstanding | 37.64 M | ||||
| Price To Earning | 4.04 X | ||||
| Price To Book | 5.76 X | ||||
| Price To Sales | 1.30 X | ||||
| Revenue | 52.35 M | ||||
| Gross Profit | 29.13 M | ||||
| EBITDA | (18.11 M) | ||||
| Net Income | (18.85 M) | ||||
| Cash And Equivalents | 20.06 M | ||||
| Cash Per Share | 0.58 X | ||||
| Total Debt | 38.5 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 4.45 X | ||||
| Book Value Per Share | 0.77 X | ||||
| Cash Flow From Operations | (5.25 M) | ||||
| Earnings Per Share | (0.82) X | ||||
| Market Capitalization | 63.62 M | ||||
| Total Asset | 79.24 M | ||||
| Retained Earnings | (54.45 M) | ||||
| Working Capital | 57.62 M | ||||
| Current Asset | 10.01 M | ||||
| Current Liabilities | 2.45 M | ||||
About Apyx Medical Performance
Evaluating Apyx Medical's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Apyx Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Apyx Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 194.83 | 115.69 | |
| Return On Tangible Assets | (0.24) | (0.22) | |
| Return On Capital Employed | (0.26) | (0.25) | |
| Return On Assets | (0.24) | (0.22) | |
| Return On Equity | (0.70) | (0.67) |
Things to note about Apyx Medical performance evaluation
Checking the ongoing alerts about Apyx Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Apyx Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Apyx Medical is way too risky over 90 days horizon | |
| Apyx Medical may become a speculative penny stock | |
| Apyx Medical appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 52.35 M. Net Loss for the year was (18.85 M) with profit before overhead, payroll, taxes, and interest of 29.13 M. | |
| Apyx Medical currently holds about 20.06 M in cash with (5.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58. | |
| Roughly 16.0% of the company shares are held by company insiders | |
| Latest headline from gurufocus.com: Apyx Medical Corporation to Participate in the Piper Sandler 36th Annual Healthcare Conference |
- Analyzing Apyx Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Apyx Medical's stock is overvalued or undervalued compared to its peers.
- Examining Apyx Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Apyx Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Apyx Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Apyx Medical's stock. These opinions can provide insight into Apyx Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Apyx Stock Analysis
When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.